Clinical Trial Update: Novel Surrogate Markers as Predictors of Radiation Toxicity in Breast Cancer Patients Undergoing Helical Tomotherapy Compared to Standard Radiation Therapy

View source ↗

Summary

A terminated clinical trial evaluated novel surrogate genetic markers to predict radiation toxicity in breast cancer patients treated with helical tomotherapy c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: AHS Cancer Control Alberta | Conditions: Genetic Markers, Cardiac Toxicity | Status: TERMINATED